Three Stocks on Watch: SHZ, CSOC, and HNSN!

November 7, 2011

China Shen Zhou Mining & Resources Inc. (AMEX:SHZ) is on the move this morning as it is trading at the high of the session at $2.22 for a 21.98% gain from Friday’s close!

SHZ is engaged in the exploration, development, mining, and processing of fluorite and nonferrous metals such as zinc, lead and copper in China. The Company has the following Read more

Force Protection will be Acquired by General Dynamics for $360M

November 7, 2011

Shares of Force Protection, Inc. (NASDAQ:FRPT) flew this morning to open the trading session at $5.50 – last trading at $5.49 for a gain of 30.29%! General Dynamics said today that it has agreed to buy Force Protection Inc., which makes armored vehicles, in a deal worth about $360 million. Read more

IZEA Holdings takes advantage of the Social Media Industry

November 6, 2011

IZEA Holdings, Inc. (OTC:IZEA) is getting a lot of attention with social media applications kicking into full gear and the good news is the stock is trading near its 52 week low of $1.15! IZEA traded over $300k in volume Friday and traded as high as $1.41 during the trading session to close at $1.35 for a 8% gain. Read more

Four Stocks under a Buck to make you forget about the NASDAQ: MILV, LEXG, SRCH, and ECPN!

November 5, 2011

Shares of Mistral Ventures Inc (PINK:MILV) continue to fly for us and since my initial alert – investors could have made as much as 69.2% as the stock has traded as high as $.10 in recent trading sessions! MILV closed out Friday’s session with an 8.81% gain at a share price of $.091, strictly with new developments from its new subsidiary – Nature’s Bioceuticals! Read more

David versus Goliath; Inhibitex challenges Pharmasset’s Territory

November 4, 2011

Inhibitex, Inc. (NASDAQ:INHX) is rocketing today as it has traded as high as $9.31 during today’s trading session and last traded at $8.85 for a stellar gain of 123.48% from yesterday’s close! INHX is a biopharmaceutical company focused on developing products to prevent and treat serious infectious diseases. The Company’s clinical-stage pipeline includes two Phase 2 development programs for which it has retained all future rights: INX-189, a nucleotide polymerase inhibitor in development for the treatment of chronic hepatitis C infections and FV-100, a nucleotide polymerase inhibitor in development for the treatment of shingles-associated pain.  Read more

Trident Microsystems crashes after reporting Weak Financials Last Night!

November 4, 2011

Trident Microsystems, Inc. (NASDAQ:TRID) has tanked hard today as it has traded as low as $.25 during the trading session and last traded at $.26 for a 50.49% loss from yesterday’s close! TRID is a leader in high-performance semiconductor system solutions for the connected home, today announced results for its third quarter ended Sept. 30, 2011. Read more

Central European Distribution plummets with its Lukewarm Q3 Financial Report

November 4, 2011

Central European Distribution Corp (NASDAQ:CEDC) is shooting to the ground as if it was a heat seeking missile accompanied with the release of its Q3 Earnings for 2011! CEDC last traded at the low of the day at a stock price of $3.19 for a substantial loss of 36.71% from yesterday’s close… Read more

Investors go Crazy for Inhibitex with its INX-189 Update

November 4, 2011

Shares of Inhibitex, Inc. (NASDAQ:INHX) utterly explode this morning with the announcement of Q3 earnings and updates on the continuation of its drug trials for INX-189! INHX has traded as high as $8.84 during the trading session and last traded at $8.66 for an incredible 118.69% gain from yesterday’s close!  Read more

Page 35 of 116« First...102030...3334353637...405060...Last »
Clicky Web Analytics